A SECRET WEAPON FOR WHO MAKES THE DIABETES DRUG COPYRIGHT

Novo Nordisk's pricing procedures from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of rate gouging, mentioning the stark contrast concerning U.S. rates and those in Europe and copyright.In October 2024, Novo Nordisk printed a examine on scientific journal Character about a novel glucose-sens